Arika Resources Limited (ASX:ARI) Upsizes Drilling Program
Arika Resources (ASX:ARI) expands its drilling program to 10,000 metres following a $5M capital raise, enhancing exploration at Yundamindra and Kookynie.
Tag: Industry-Specific News
Chrysos Corporation Limited (ASX:C79) Signs Master Services Agreement with Newmont Corporation
Chrysos Corporation Limited (ASX:C79) enters into a Master Services Agreement with Newmont Corporation for its PhotonAssay technology.
Culpeo Minerals (ASX:CPO) Secures $3 Million for Copper Drilling Projects
Culpeo Minerals (ASX:CPO) raises $3 million to advance high-grade copper projects in Chile, focusing on the Lana Corina discovery.
Australian Vanadium Limited (ASX:AVL) Advances Project Lumina with Improved LCOS
Australian Vanadium Limited (ASX:AVL) progresses Project Lumina, achieving a competitive LCOS for its vanadium flow battery energy storage system.
Orthocell Limited (ASX:OCC) Accelerates US Remplir™ Sales Rollout with 12 Distributors
Orthocell Limited (ASX:OCC) accelerates Remplir™ sales rollout with 12 US distributors, surpassing targets and setting the stage for first sales.
Jameson Resources (ASX:JAL) Releases Feasibility Update for Crown Mountain Coal Project
Jameson Resources (ASX:JAL) updates feasibility for Crown Mountain Coal Project, highlighting increased reserves and financial outlook.
Gumtree Australia Markets Limited (ASX:GUM) Signs MOU with NZME
Gumtree (ASX:GUM) signs an MOU with NZME to develop a new digital automotive marketplace in New Zealand.
Acrux Limited (ASX:ACR) Launches Dapsone 7.5% Gel in the United States
Acrux Limited (ASX:ACR) launches its differentiated Dapsone 7.5% Gel in the US, enhancing its prescription acne treatment portfolio.
Tempest Minerals Limited (ASX:TEM) Announces Inaugural Resource Estimate
Tempest Minerals (ASX:TEM) announces a 63.5 Mt @ 30.6% Fe inaugural resource estimate for the Remorse Deposit, paving the way for future development.
LTR Pharma Limited (ASX:LTP) Signs Collaborative Agreement for OROFLOW® Development
LTR Pharma (ASX:LTP) collaborates with SDS to develop OROFLOW®, a novel intranasal spray for Oesophageal Motility Disorders.